Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: Abbott
Abbott to Purchase Solvay for $6.6 Billion (Update 1)
Abbott announced, early Monday morning, that it had signed a deal to purchase Belgium-based drug manufacturer Solvay Pharmaceuticals for $6.6 billion in cash—a mere five months after Solvay’s CEO Werner Cautreels announced that the company was searching for a proper suitor.
The deal adds more than $3 billion in annualized sales to its global pharmaceutical business—three-quarters [...]
AZ, Sepracor, and Abbott Cinch Belts With Layoffs
It’s been a tough few days for pharmaceutical employees. Just days after Pfizer announced that it would eliminate 10 percent of its workforce, three other companies are revealing restructuring plans that include releasing hundreds (and in one case thousands) of employees.
In its fourth quarter report released today, AstraZeneca stated that it will continue its “new [...]
The KOL Database Kingdom
Tracking interactions with KOLs can be a daunting task if you don’t have the right systems in place. Similar to the children’s mythology-themed boardgame, “Key to the Kingdom,” the odds of mastering it at first try are slim—but over time, you learn from mistakes, become familiar with the rules, and ultimately succeed.
Michael Schaffer, senior district [...]
An Inevitable Evolution
It is all about the pull and less about the push when it comes to delivering an effective and valuable message to physicians without comprising compliance. And the panelists and speakers attending the Center for Business Intelligence’s Premier Opinion Leader Management Systems conference in King of Prussia, PA, couldn’t agree more.
Over the next five years, [...]
Posted in Marketing, People Also tagged Cegedim Dendrite, Gartner, key opinion leader, UCB Pharma Leave a comment

Saving Haiti: One Donation at a Time (UPDATED 1/21)